BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35433960)

  • 1. The development of a redox-sensitive curcumin conjugated chitosan oligosaccharide nanocarrier for the efficient delivery of docetaxel to glioma cells.
    Liu C; Gao Y; Zhao L; Wang R; Xie F; Zhai G; Liu A
    Ann Transl Med; 2022 Mar; 10(6):297. PubMed ID: 35433960
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
    Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
    Dou J; Zhang H; Liu X; Zhang M; Zhai G
    Colloids Surf B Biointerfaces; 2014 Feb; 114():20-7. PubMed ID: 24157590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
    Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
    Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocomposite of chitosan/gelatin/carbon quantum dots as a biocompatible and efficient nanocarrier for improving the Curcumin delivery restrictions to treat brain cancer.
    Ostovar S; Pourmadadi M; Shamsabadipour A; Mashayekh P
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):124986. PubMed ID: 37230449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the cellular uptake and biodistribution of a dual-targeting carrier based on redox-sensitive hyaluronic acid-ss-curcumin micelles for treating brain glioma.
    Tian C; Asghar S; Hu Z; Qiu Y; Zhang J; Shao F; Xiao Y
    Int J Biol Macromol; 2019 Sep; 136():143-153. PubMed ID: 31199976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene Glycol-Chitosan Oligosaccharide-Coated Superparamagnetic Iron Oxide Nanoparticles: A Novel Drug Delivery System for Curcumin Diglutaric Acid.
    Sorasitthiyanukarn FN; Muangnoi C; Thaweesest W; Bhuket PRN; Jantaratana P; Rojsitthisak P; Rojsitthisak P
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
    Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
    Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
    Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
    Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox responsive xylan-SS-curcumin prodrug nanoparticles for dual drug delivery in cancer therapy.
    Sauraj ; Vinay Kumar ; Kumar B; Priyadarshi R; Deeba F; Kulshreshtha A; Kumar A; Agrawal G; Gopinath P; Negi YS
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110356. PubMed ID: 31761247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment.
    Hu Y; Ran M; Wang B; Lin Y; Cheng Y; Zheng S
    Int J Nanomedicine; 2020; 15():9703-9715. PubMed ID: 33299312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
    Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
    Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
    Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
    Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Hyaluronic Acid-Decorated Redox-Responsive Magnetic Complex Micelle for Targeted Drug Delivery with Enhanced Antitumor Efficiency and Anti-Cell-Migration Activity.
    Sang M; Zhang Z; Liu F; Hu L; Li L; Chen L; Feng F; Liu W; Qu W
    J Biomed Nanotechnol; 2018 Mar; 14(3):477-495. PubMed ID: 29663921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
    Wu H; Liu Y; Chen L; Wang S; Liu C; Zhao H; Jin M; Chang S; Quan X; Cui M; Wan H; Gao Z; Huang W
    Int J Nanomedicine; 2022; 17():6377-6398. PubMed ID: 36545220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
    Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
    Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells.
    Wang K; Zhang T; Liu L; Wang X; Wu P; Chen Z; Ni C; Zhang J; Hu F; Huang J
    Int J Nanomedicine; 2012; 7():4487-97. PubMed ID: 22927762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.